Bullous Pemphigoid
📧 Sign up to get email alerts when something new happens for Bullous Pemphigoid.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid [Phase 3]
Phase 3 clinical trial evaluating topical steroids alone or with methotrexate for bullous pemphigoid has completed. The record notes the stu…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid [Phase 3]
A Phase 3 trial evaluating the efficacy and tolerability of Rituximab (MabThera) in Bullous Pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody [Phase 2]
Phase 2 clinical trial evaluating avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody, for bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of dupilumab in adult patients with bullous pemphigoid has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid [Phase 3]
A Phase 3 study evaluating the long-term safety, tolerability, and efficacy of Efgartigimod PH20 SC in adults with bullous pemphigoid has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid [Phase 4]
Phase 4 clinical trial evaluating fluid retention associated with a superpotent topical corticosteroid in bullous pemphigoid has completed. …
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid [Phase 2]
Phase 2 trial evaluating Bertilimumab in bullous pemphigoid. Results addressing safety, efficacy and pharmacodynamic effects were posted.
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid [Phase 2, Phase 3]
A Phase 2/3 study assessing subcutaneous efgartigimod with PH20 for Bullous Pemphigoid has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.
A completed clinical trial update assessing the prevalence of sleep disturbances in patients with Bullous Pemphigoid.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid [Phase 4]
Phase 4 trial comparing add-on dapsone versus add-on methotrexate for efficacy and safety in bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects [Phase 2]
Clinical trial update indicating completion of a Phase 2 study of rVA576 in adults with mild to moderate Bullous Pemphigoid.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. [Phase 3]
A Phase 3 trial evaluating benralizumab for Bullous Pemphigoid was terminated and results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: JAK Inhibitors' Efficacy in Bullous Pemphigoid
A completed clinical trial evaluating the efficacy of Janus kinase inhibitors in treating bullous pemphigoid has been updated.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid [Phase 2]
A Phase 2 trial of adjunctive AKST4290 for bullous pemphigoid was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Efficacy and Safety of Ustekinumab in Bullous Pemphigoid [Phase 2]
Phase 2 trial assessing efficacy and safety of ustekinumab in bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid [Phase 4]
Phase 4 clinical trial investigating how dermocorticoids affect bone mineral density in patients with bullous pemphigoid, with osteoporosis …
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid [Phase 3]
Phase 3 trial update investigating ozonated olive oil for Pemphigus Vulgaris and Bullous Pemigoid; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Ixekizumab in the Treatment of Bullous Pemphigoid [Phase 2]
Phase 2 clinical trial evaluating ixekizumab for bullous pemphigoid has completed and results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
A clinical trial investigating the role of proteasomes in bullous pemphigoid has been terminated; the study included bullous pemphigoid, pem…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Anti-IL-5 Therapy in Bullous Pemphigoid (BP) [Phase 2]
Phase 2 clinical trial evaluating anti-IL-5 therapy for bullous pemphigoid has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid
A completed clinical trial assessing the effect of different dosages of Anti-PB230, Anti-PB180 and cytokines for monitoring Bullous Pemphigo…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment [Phase 2]
A Phase 2 trial assessing the safety, efficacy, and PK/PD of QGE031 versus placebo in patients with active bullous pemphigoid on oral steroi…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids [Phase 3]
Phase 3 clinical trial evaluating NPB-01 in bullous pemphigoid patients unresponsive to corticosteroids has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus
A completed clinical trial comparing two therapeutic strategies using Dermoval for Bullous Pemphigoid.
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Rituximab in the Treatment of Patients With Bullous Pemphigoid [Phase 1, Phase 2]
This clinical trial evaluated rituximab for bullous pemphigoid in Phase 1/2, and results were posted in 2012.